BPC-157 for Athletes
BPC-157 (Body Protection Compound-157) is a 15-amino acid peptide fragment of human gastric juice protein BPC. In preclinical models it consistently accelerates tendon, ligament, and muscle repair by upregulating growth factor receptors, promoting angiogenesis, and stimulating collagen synthesis — making it one of the most researched peptides for athletic injury recovery.
Why BPC-157 Works for Athletic Injuries
BPC-157 upregulates EGR1 (early growth response protein 1) and VEGFR2 (vascular endothelial growth factor receptor 2), amplifying the body's natural repair signaling cascade at the injury site.
Promotes new blood vessel formation at the injury site, increasing oxygen and nutrient delivery to the healing tissue — critical for tendon and ligament repair, which are naturally hypovascular.
Stimulates fibroblast proliferation and collagen type I synthesis, the primary structural protein in tendons and ligaments. Improves collagen organization and tensile strength of repaired tissue.
Modulates the nitric oxide system to reduce oxidative stress and inflammation at the injury site without the immunosuppressive effects of corticosteroids, preserving the repair response.
BPC-157 Dosage Protocol for Athletes
| Phase | Dose | Timing | Notes |
|---|---|---|---|
| Week 1–2 | 250mcg/day | Once daily, near injury | Assess tolerance; some users report mild injection site redness |
| Week 3–6 | 500mcg/day | Once daily or split 250mcg 2x | Primary therapeutic window; most users see peak benefit here |
| Week 7–12 | 250–500mcg/day | Based on response | Maintain or taper based on injury resolution; some continue at 250mcg for consolidation |
| Off cycle | None | 4–8 weeks off | Allow receptor sensitivity to reset; reassess injury status before next cycle |
Injury-Specific Applications
| Injury Type | Dose | Injection Site | Duration | Evidence |
|---|---|---|---|---|
| Achilles tendon | 500mcg/day | Near Achilles insertion | 6–8 weeks | Strong preclinical |
| Rotator cuff | 500mcg/day | Deltoid region SubQ | 6–10 weeks | Moderate preclinical |
| Patellar tendon | 500mcg/day | Near patellar tendon | 6–8 weeks | Strong preclinical |
| Muscle strain (Grade I–II) | 500mcg/day | Near muscle belly | 2–4 weeks | Moderate preclinical |
| Ligament sprain (Grade I–II) | 500mcg/day | Near ligament | 4–8 weeks | Moderate preclinical |
| Stress fracture | 500mcg/day | Systemic SubQ | 6–12 weeks | Limited preclinical |
All evidence is preclinical (animal models). No randomized controlled trials in humans have been completed for BPC-157 in athletic injury applications.
BPC-157 + TB-500: The Athlete Recovery Stack
- • 500mcg/day SubQ near injury site
- • Inject within 1–2 inches of target tissue
- • Continue for 4–8 weeks
- • Provides: collagen synthesis, local angiogenesis, growth factor upregulation
- • 2mg twice weekly SubQ (abdomen)
- • Systemic injection, not localized
- • Continue for 4–8 weeks
- • Provides: systemic anti-inflammation, cell migration, DOMS reduction
BPC-157 from Purgo Labs
≥99% purity, third-party COA verified, cGMP facility. Ships with reconstitution guide.
Use code HEALTH for 15% off.
Shop BPC-157Frequently Asked Questions
What is the best BPC-157 dose for athletes?
The most commonly researched dose for athletic injury recovery is 250–500mcg per day, injected subcutaneously near the injury site. Some protocols use 200–300mcg twice daily. For systemic anti-inflammatory effects, 500mcg once daily is standard. Doses above 500mcg/day have not shown proportionally greater benefit in preclinical models.
Should athletes inject BPC-157 near the injury or systemically?
For localized injuries (tendon, ligament, specific muscle), injecting near the injury site (within 1–2 inches) produces the strongest local effect by concentrating the compound at the target tissue. For systemic recovery or gut health, subcutaneous injection in the abdomen works well. Many athletes use local injection for the primary injury and systemic injection for general recovery.
How long does BPC-157 take to work for tendon injuries?
Most athletes report noticeable improvements in pain and mobility within 1–2 weeks. Tendon and ligament injuries typically show meaningful progress at 4–6 weeks. Muscle injuries often respond faster (1–3 weeks). Chronic injuries (6+ months old) may require 8–12 weeks for full benefit. BPC-157 accelerates the underlying repair process rather than masking pain.
Can BPC-157 be used during active training?
Yes — BPC-157 can be used during active training. It does not impair performance or cause sedation. Many athletes continue training (at reduced intensity for the injured area) while using BPC-157, as the compound supports tissue repair even under mechanical load. Some preclinical evidence suggests that moderate loading of the healing tissue may enhance the repair response.
What is the best BPC-157 stack for athletes?
The most common stack is BPC-157 + TB-500: BPC-157 500mcg/day near the injury site + TB-500 2mg twice weekly systemically. This combination covers both local repair (BPC-157) and systemic anti-inflammation and angiogenesis (TB-500). For athletes also focused on body composition, adding CJC-1295 + Ipamorelin pre-sleep provides GH optimization on top of the repair stack.
Is BPC-157 prohibited in sports?
Yes. BPC-157 is classified under WADA's Prohibited List as a peptide hormone (S2 category). Athletes subject to drug testing by WADA, USADA, or any major sports federation should not use BPC-157. This guide is for research and educational purposes only.